Global
Biologics and Biosimilars
Market Analysis 2022–2034
Biologics and Biosimilars Industry Overview
Cognitive Market Research tracks the Biologics and Biosimilars industry as part of the Pharmaceuticals sector, covering market size, share, growth forecasts, pricing, regional demand and the competitive landscape. Our analysts combine primary interviews with industry experts and secondary research to help companies size opportunities, benchmark competitors and plan entry and expansion strategies.
Explore Biologics and Biosimilars Sub-Industries
List of Biologics and Biosimilars Industry Reports
Global
Biologics and Biosimilars
Market Analysis 2022–2034
Global
Biologics and Biosimilars
Market Analysis 2022–2034
Global
Biologics and Biosimilars
Market Analysis 2022–2034
Global
Biologics and Biosimilars
Market Analysis 2022–2034
Global
Biologics and Biosimilars
Market Analysis 2022–2034
Global
Biologics and Biosimilars
Market Analysis 2022–2034
Global
Biologics and Biosimilars
Market Analysis 2022–2034
Global
Biologics and Biosimilars
Market Analysis 2022–2034
Global
Biologics and Biosimilars
Market Analysis 2022–2034
Global
Biologics and Biosimilars
Market Analysis 2022–2034
Global
Biologics and Biosimilars
Market Analysis 2022–2034
Biologics and Biosimilars Industry Statistics & Data Insights
| Product / Industry | Unit | 2021Base year | 2025Current | 2033Forecast | CAGRGrowth rate |
|---|---|---|---|---|---|
| Biosimilars Market | Million | 12,627 |
23,964 |
86,313 |
17.372% |
| Monoclonal Antibodies Product Market | Billion | 159 |
222 |
436 |
8.77% |
| Monoclonal Antibodies Market | Billion | 183 |
291 |
735 |
12.28% |
| Interferon Alpha-2a Biosimilar Sales Market | Million | 540 |
790 |
1,694 |
10% |
| Interferon Biosimilar Market | Million | 2,336 |
3,435 |
7,428 |
10.12% |
| Interferon Alpha 2b Biosimilar Market | Million | 915 |
1,054 |
1,399 |
3.6% |
| Adalimumab Biosimilar Market | Million | 380 |
779 |
3,504 |
20.67% |
| Infliximab and biosimilar Market | Million | 6,286 |
8,721 |
16,789 |
8.531% |
| Infliximab Biosimilar Market | Million | 2,006 |
3,218 |
8,281 |
12.539% |
| Trastuzumab Biosimilar Market | Million | 2,213 |
3,898 |
12,091 |
15.2% |
| Bevacizumab Biosimilar Market | Million | 1,573 |
3,818 |
24,439 |
26.12% |
| Generic and Biosimilar Pharmaceuticals Market | Billion | 314 |
418 |
745 |
7.473% |
≥10% High growth5–9% Mid<5% Low
Biologics and Biosimilars Sub-Industry Athenaeum
Athenaeum gives you on-demand access to market data, forecasts and company intelligence across every Biologics and Biosimilars segment — in one searchable research library.